Exhibit 10.2
MAJORITY WRITTEN CONSENT
OF THE BOARD OF DIRECTORS
OF
Curascientific Corporation
On December 6, 2023, the undersigned, constituting the majority members of the Board of Directors (the “Board”) of Curascientific Corporation, a Florida Corporation (the “Company”), hereby consent to, adopt, ratify, and confirm the following resolutions:
WHEREAS, the Company has received resignations from Paul Goyette and Chris Bennet, both Directors of the company, respectively.
On December 6, 2023 the company received a resignation letter from Paul Goyette, attached hereto as Exhibit A. Paul was appointed a Director on 9/29/2022.
On December 6, 2023 the company received a resignation letter from Chris Bennet, attached hereto as Exhibit B. Chris was appointed a Director of 5/26/2023 and as Chief Marketing Officer. Further, he was engaged under an Employment Contract on 5/26/2023.
NOW, THEREFORE, BE IT:
RESOLVED, the Company has dismissed Director(s) Paul Goyette and Chris Bennett pursuant their resignations. Further, the company has terminated the Employment Agreement with Chris Bennett. Any/all unpaid salary and/or considerations for either Director or Employee will be converted to Preferred Series A Stock at equal value.
FURTHER RESOLVED, that all actions by the undersigned in connection with or in furtherance of any of the foregoing matters be and hereby are approved, authorized, confirmed and ratified in all respects by the Company. This written consent may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same instrument.
Signatures to this written consent delivered by facsimile or in .pdf or other electronic format shall be acceptable and binding and treated in all respects as having the same effect as an original signature.
INWITNESS WHEREOF, the undersigned, being all the members of the Board of the Company, has executed this written consent as of the date first written above.
DIRECTOR:
|
|
William Reed, Chairman and CEO |
Majority Shareholder |
EXHIBIT A
Attorneys Paul Q. Goyette Daniel P. Thompson Rafael Ruano Brett F. Sherman Nicole Valentine Richard P. Fisher Scott Nelson David J. Garcia lan D. Woo Eric R Acevedo Janelle Crandell Alison Gilmore Derek K Ulmer Brandon Largent*
Of Counsel Mark Peacock Megan Bartlett | | Labor Representatives: Tony Silva Tim Cantillon Jon Crawford Kim Gillingham Tony Arguelles Dorothea Contreras
Sacramento Office 2366 Gold Meadow Way, Suite 200 Gold River, CA 95670 (916) 851-1900 Toll Free (888) 993-1600 Facsimile (916) 85l-1995 |
December 6, 2023
CuraScientific, Inc. |
Board of Directors |
51544 Cesar Chavez Street, Suite 1J |
Coachella, CA 92236 |
joe@curascientificcorp.com |
joereed@calicaregroup.com |
justin@boonindusties.com |
chris@calicaregroup.com |
| Re: | Resignation from Board of Directors |
Dear gentlemen:
Please accept this letter as my resignation from the Board of Directors of CuraScientific, Inc. which, as you know, is a publicly traded corporation. Recently, other business opportunities have arisen that will require my full attention as well as my disengagement from certain other projects I am currently involved in. It has been a pleasure working with you. It is my understanding that this resignation correspondence must be filed with the SEC. I would appreciate it if you could see to it through Zev Bomrind or the other appropriate lawyer that this is accomplished. Please let me know if you have any questions. Good luck to you all moving forward.
| GOYETTE, RUANO & THOMPSON |
| A Professional Law Corporation |
| |
| |
| Paul Q. Goyette, Esq. |
| |
| * Provisionally Licensed Lawyer per California Rule of Court 9.49(e)(2), (e)(3). |
EXHIBIT B
December 6, 2023
To: | William Reed, CEO |
| Curascientific Corp. |
From: | Chris Bennett, CMO/Director |
RE: Resignation from Curascientific Corp
Effective today, Please accept my resignation as a Director, CMO and as an Employee of Curascientific Corp., as I will remain as a consultant with Cal Care Grp. Inc. I have pursued other interests at this time. Thank you.
Respectfully,
Chris Bennett